A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 14 04 2022
accepted: 06 06 2022
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 3 8 2022
Statut: epublish

Résumé

Immune-related processes are important in underpinning the properties of clinical traits such as prognosis and drug response in cancer. The possibility to extract knowledge learned by artificial neural networks (ANNs) from omics data to explain cancer clinical traits is a very attractive subject for novel discovery. Recent studies using a version of ANNs called autoencoders revealed their capability to store biologically meaningful information indicating that autoencoders can be utilized as knowledge discovery platforms aside from their initial assigned use for dimensionality reduction. Here, we devise an innovative weight engineering approach and ANN platform called artificial neural network encoder (ANNE) using an autoencoder and apply it to a breast cancer dataset to extract knowledge learned by the autoencoder model that explains clinical traits. Intriguingly, the extracted biological knowledge in the form of gene-gene associations from ANNE shows immune-related components such as chemokines, carbonic anhydrase, and iron metabolism that modulate immune-related processes and the tumor microenvironment play important roles in underpinning breast cancer clinical traits. Our work shows that biological "knowledge" learned by an ANN model is indeed encoded as weights throughout its neuronal connections, and it is possible to extract learned knowledge

Identifiants

pubmed: 35911770
doi: 10.3389/fimmu.2022.920669
pmc: PMC9330471
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

920669

Subventions

Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA229100
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA240323
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG050618
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA136393
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG061796
Pays : United States

Informations de copyright

Copyright © 2022 Zhang, Correia, Weiskittel, Tan, Meng-Lin, Yu, Yao, Yeo, Zhu, Ung and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Nature. 2017 Oct 18;550(7676):354-359
pubmed: 29052630
Bull Math Biol. 1990;52(1-2):99-115; discussion 73-97
pubmed: 2185863
Mol Cancer. 2013 Sep 27;12(1):111
pubmed: 24070020
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17778-83
pubmed: 24128763
PLoS One. 2015 Sep 03;10(9):e0137204
pubmed: 26334757
Cancer Res. 2011 Nov 1;71(21):6728-37
pubmed: 21875943
Drug Discov Today. 2018 Jun;23(6):1241-1250
pubmed: 29366762
JAMA. 2011 May 11;305(18):1873-81
pubmed: 21558518
PLoS Biol. 2008 Jan;6(1):e16
pubmed: 18232737
Nat Rev Immunol. 2008 Jan;8(1):59-73
pubmed: 18097448
Cancer Res. 2016 Mar 1;76(5):1204-13
pubmed: 26837760
Nat Rev Cancer. 2015 Feb;15(2):96-109
pubmed: 25614008
Nature. 2016 Oct 05;538(7623):20-23
pubmed: 27708329
Int J Cancer. 2009 Jan 15;124(2):333-8
pubmed: 18942707
Nature. 2021 Oct;598(7880):348-352
pubmed: 34552244
Genomics. 2012 Dec;100(6):337-44
pubmed: 22959562
Cells. 2021 Feb 02;10(2):
pubmed: 33540645
Cancers (Basel). 2020 Nov 11;12(11):
pubmed: 33187209
Nat Rev Neurosci. 2012 Jun 20;13(7):478-90
pubmed: 22714019
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
Nature. 2017 Aug 9;548(7666):175-182
pubmed: 28796202
Cell Mol Immunol. 2022 Mar;19(3):432-444
pubmed: 34983949
Anticancer Res. 2007 Jul-Aug;27(4C):2649-55
pubmed: 17695428
Int J Clin Exp Med. 2015 Mar 15;8(3):4228-35
pubmed: 26064334
Cancer. 2001 Jun 15;91(12):2214-21
pubmed: 11413508
Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):1007-11
pubmed: 9276366
Ageing Res Rev. 2017 Nov;40:84-94
pubmed: 28941639
Psychol Rev. 1958 Nov;65(6):386-408
pubmed: 13602029
Int J Cancer. 1994 Feb 1;56(3):364-9
pubmed: 8314323
Clin Cancer Res. 2003 Jan;9(1):207-14
pubmed: 12538471
Front Cell Dev Biol. 2021 Oct 18;9:739161
pubmed: 34733848
Drug Resist Updat. 2003 Aug;6(4):169-72
pubmed: 12962682
J Clin Oncol. 2006 Jul 1;24(19):3039-47
pubmed: 16809728
Oncotarget. 2017 Jan 3;8(1):1569-1579
pubmed: 27906669
Pac Symp Biocomput. 2018;23:80-91
pubmed: 29218871
IEEE Eng Med Biol Mag. 1990;9(3):15-8
pubmed: 18238341
World J Surg. 2014 Aug;38(8):2046-51
pubmed: 24615604
Science. 2012 Jul 27;337(6093):437-44
pubmed: 22837521
Nat Rev Neurosci. 2004 Jan;5(1):45-54
pubmed: 14708003
J Clin Oncol. 2008 May 20;26(15):2568-81
pubmed: 18487574
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Cancer. 1991 Dec 1;68(11):2407-10
pubmed: 1657354
Cancer Chemother Pharmacol. 2010 Feb;65(3):447-55
pubmed: 19543729
Nature. 2020 Jan;577(7792):706-710
pubmed: 31942072
Trends Neurosci. 2014 Oct;37(10):604-14
pubmed: 25257207
Science. 2006 Jul 28;313(5786):504-7
pubmed: 16873662
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Methods. 2018 Apr;15(4):290-298
pubmed: 29505029
Nat Rev Cancer. 2021 Jun;21(6):345-359
pubmed: 33837297
Neuron. 2011 Mar 24;69(6):1160-75
pubmed: 21435560
Trends Neurosci. 2012 Jun;35(6):345-55
pubmed: 22579264
Oncoimmunology. 2014 Jan 1;3(1):e27884
pubmed: 24790795
Breast Cancer Res Treat. 2009 Nov;118(1):45-56
pubmed: 18925433
J Cell Sci. 2020 Mar 6;133(5):
pubmed: 32144194
Pac Symp Biocomput. 2015;:132-43
pubmed: 25592575
Bioinformatics. 2019 Oct 1;35(19):3735-3742
pubmed: 30825303
J Clin Oncol. 2015 Mar 20;33(9):983-91
pubmed: 25534375
Nat Rev Neurosci. 2005 Feb;6(2):119-30
pubmed: 15685217
Mol Med Rep. 2009 Jul-Aug;2(4):549-53
pubmed: 21475864
BMC Cancer. 2014 Jun 04;14:400
pubmed: 24893880
mSystems. 2016 Jan 19;1(1):
pubmed: 27822512
Nat Med. 2015 Oct;21(10):1128-38
pubmed: 26444637
Nat Med. 2019 Jan;25(1):24-29
pubmed: 30617335
Biol Cybern. 1980;36(4):193-202
pubmed: 7370364
J Clin Oncol. 2008 Feb 10;26(5):778-85
pubmed: 18258986
Elife. 2021 Sep 01;10:
pubmed: 34468313
Science. 2000 Feb 18;287(5456):1273-6
pubmed: 10678835
Front Immunol. 2020 May 15;11:940
pubmed: 32499786

Auteurs

Cheng Zhang (C)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Cristina Correia (C)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Taylor M Weiskittel (TM)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Shyang Hong Tan (SH)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Kevin Meng-Lin (K)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Grace T Yu (GT)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Jingwen Yao (J)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Kok Siong Yeo (KS)

Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Shizhen Zhu (S)

Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Choong Yong Ung (CY)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Hu Li (H)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH